Nordic BioSite supports Norwegian Immunology Society annual meeting
Press Release | Nordic Biosite AB
NOVEMBER 07, 2017
Täby, Sweden: – Nordic BioSite, the leading Scandinavian supplier of validated biotechnology products, will be a leading presence at next week’s Norwegian Society for Immunology annual meeting, NSI 2017, in Oslo.
As a leading member of the Nordic life sciences community and supporter of the NSI, Nordic BioSite has deep links with the society.
BioSite’s Area Manager for Norway, Dr. Johanna Gottschamel, will lead its presence at the event in Oslo.
Molecular biology research
“We attended last year’s NSI annual meeting and are delighted to be returning to this important Scandinavian academic event as a sponsor and partner,” said Dr. Gottschamel.
“Once again, it will provide us with an excellent platform for extending our links with researchers and supplying customers with latest information and opportunities to support their research work,” she added.
Nordic BioSite will use the co-located exhibition to showcase its most popular products for molecular biological research.
Immune therapy support
“We will be able to present NSI members who are researchers, group leaders and students working within the immunology and immune therapy fields with a wide range of high quality products, materials and services that are relevant to their tasks,” said Dr. Gottschamel.
Nordic BioSite’s product portfolio includes blocking antibodies, proteins and flow cytometry antibodies product derived from PD-1, PD-L1 and PD-L2 as well as immunohistochemistry and WB Antibodies for PD-1 and PD-L1.
About Nordic BioSite
Since the late 1990s, Nordic BioSite has become recognized as one of the pharma industry’s most innovative and customer-responsive supplier of high quality validated biotechnology products for research, diagnostics, immunology and molecular biology.
The company serves pharmaceutical, biotech, diagnostic and academic organizations with tens of thousands of different products in more than 30 different groups, ranging from antibodies to genetic vectors. These are sourced from selected manufacturers and laboratories in Europe, the Americas and Asia.
Nordic BioSite continuously introduces new products as a result of its own R&D, leveraged by close partnerships with manufacturers and feedback from customers.
Nordic BioSite’s company strapline, By Your Side™, defines a company ethos of partnering life science customers, helping to find the right products and services to help reach chosen goals across the whole spectrum of biotech research areas.
Nordic BioSite also operates as a CRO through its Finnish-based cGLP laboratory, BioSiteHisto. This offers a wide range of leading-edge research-based custom laboratory services including histology, immunochemistry, in vitro research and testing, antibody optimization, antibody conjugation and predesigned adenylated linkers for Next Generation sequencing.
About NSI 2017
The Norwegian Society for Immunology (NSI) is an association of immunologists in Norway that arranges meetings for national and international audiences.
The society’s 35h Annual Meeting (NSI 2017) will be a one-day event on November 17 at the Runde Auditorium of the Domus Medica, the main teaching site for medical students at Oslo University.
The event will include a keynote lecture by Professor Richard Holmdahl from Karolinska Institutet in Sweden, along with presentations by Professor Mats Ohlin of Sweden’s Lund University, and Associate professor Peter Kristensen of Aarhus University, Denmark, as well as invited national speakers and short talks selected from the submitted abstracts. An afternoon poster session will be followed by the NSI General Assembly, concluding with the society’s Annual Dinner.
The event is organised by the Norwegian Society of Immunology, with more information at: http://norwegianimmunology.org/annualmeeting2017/.
Jenny Wiklund, Marketing Coordinator, Nordic BioSite AB
Tel: +46 (0) 8 5444 3341 / +46 (0)709 35 95 57
Supplier: Nordic Biosite
Address: Propellervägen 4A, 183 62 Täby, Sweden
Tel: +46 (0)8 544 433 40
Fax: +46 (0)8 756 94 90